Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
Titel:
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
Auteur:
Aroda, Vanita R Aberle, Jens Bardtrum, Lars Christiansen, Erik Knop, Filip K Gabery, Sanaz Pedersen, Sue D Buse, John B